Today in Peak History (May 1-May 10)
Release time:
2020-08-14
peak history (5# March 1 - 5# July 10 )
1958 5 , Zhejiang provincial planning Committee issued document [1958]177 , approving the land acquisition and construction of Jinhua cement plant. After several times of investigation and demonstration, the site is selected to the east of Qianzhuangtou Village in Anshi Township (now Luodian Town) eight kilometers north of Wuwu, Jinhua, and to the south of Wizhiji, with a land acquisition area of 16.94 mu.
1975 5 July, Jinhua Cement Plant promoted the use of bulk cement for the first time, selling bulk cement 4594 tons in Jinhua and Lishui areas during the year, accounting for 8% of the cement delivered.
1977 5 August, the loading belt conveyor in the finished product workshop of Jinhua Cement Factory was successfully renovated. Since then, it has bid farewell to the history that the cement factory needs to push the warehouse before manual loading.
1989 5 In May, Du Zihong, then chairman and general manager, was named an outstanding entrepreneur in Zhejiang Province.
1993 5 February, Jianfeng Group's shares were registered under custody by Zhejiang Securities Registration Center.
1999 5 In September, Zhejiang Jianfeng Group launched the "Detailed Rules for the Implementation of Factory Affairs Disclosure". The system includes more than ten contents, such as major decision-making, production and operation objectives, business entertainment expenses, material procurement, personnel employment and distribution system, democratic evaluation and appointment and removal of cadres, and disclosure of employee welfare. It is an important measure for the democratic management of peak enterprises.
2003 5 , the peak public bonded warehouse was approved by the General Administration of Customs to be established. It is the first newly approved enterprise in the country since 1998 and the third bonded warehouse in Zhejiang Province.
2005 5 In May, Jianfeng Pharmaceutical Company won the title of "National Key High-tech Enterprise.
2010 5# In August and February, Jianfeng Group won the title of demonstration unit of Zhejiang Province's "Creating Learning Organization and Striving to Be Knowledge Workers" activity. ◆
5 September 9 , Jianfeng Group and Jinhua Vocational and Technical College signed a strategic cooperation agreement. With the purpose of "mutual benefit, complementary advantages, collaborative cooperation, and common progress", this cooperation establishes and develops friendly strategic cooperative relations, and further gathers the strength of universities and enterprises by integrating the resources of both parties, and promotes the common development of schools and enterprises. ◆
August, daye peak cement company denitration project passed the environmental protection acceptance. The company thus became the first implementation of denitrification in Hubei Province, the cement production enterprises.
5 05 2 day, peak's first online store, Sunimei's official flagship store, opened in Tmall Mall and successfully realized product sales, which marked a new chapter in the development of peak biotechnology company's e-commerce. ◆
# May# November and April, Daye Peak Cement Company was included in Hubei Province's carbon emission trading pilot enterprise. ◆ 2016
5# December, the party Committee of the group company started the "two studies and one job" study and education work. (Xu Xia finishing)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31